The global spread of COVID-19 is keeping people at home. Much of the world is on lockdown, and even in […]
Author: Ray El Boustany
CoviDIAB
CoviDIAB Personalized support during the coronavirus epidemic For diabetic patients confined during the COVID-19 epidemic, the AP-HP, in partnership with […]
J-P. Riveline publishes in JCEM
Exposure to Glucocorticoids in the First Part of Fetal Life is Associated with Insulin Secretory Defect in Adult Humans Type […]
L. Potier publishes in Diabetes Care
Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes Lower-extremity amputation (LEA) is a major […]
F. Fumeron publishes in Mol Metab
New roles for prokineticin 2 in feeding behavior, insulin resistance and type 2 diabetes: Studies in mice and humans The […]
S. Girardot publishes in Diabetes Technol Ther
Kalman Filter-Based Novel Methodology to Assess Insulin Pump Accuracy Continuous subcutaneous insulin infusion is one of the best ways to […]
IMMEDIAB retreat 2019
On the 19th of June, the entire Immediab team hopped on a train at Gare de Lyon, for the team’s […]
F. Fumeron publishes in Diabetes & Metabolism
Dairy consumption is associated with lower plasma dihydroceramides in women from the D.E.S.I.R. cohort Type 2 diabetes is a multifactorial […]
Congratulations to our 2019 Interns
This year, the Immediab crew expanded as the lab welcomed three Master’s students for their research internship – Diane, Judith […]
L. Potier publishes in Diabetologia
Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use Lower limb […]
